While this study provides valuable insights into the dynamics of malignant transformation in GATA2 deficiency, a rare disease in children, and its potential therapeutic implications, it is important to consider the small sample size of six patients in the GATA2-EB group, which may have some impact on statistical power. This evidence concerns the gene GATA2 and hyperinsulinemic hypoglycemia, familial, 4.